Dr. Assis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
40 Temple Street, Suite 1A
Temple Medical Center
New Haven, CT 06510
Education & Training
Yale-New Haven Medical CenterFellowship, Transplant Hepatology, 2012 - 2013- Yale-New Haven Medical CenterFellowship, Gastroenterology, 2009 - 2012
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2005 - 2009
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005
Certifications & Licensure
- CT State Medical License 2013 - 2025
- PA State Medical License 2005 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis Start of enrollment: 2011 Oct 01
- Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis Start of enrollment: 2017 Apr 14
Publications & Presentations
PubMed
- autoimmune hepatitis? - Summary of the 5international autoimmune hepatitis group research workshop 2024.Bastian Engel, David N Assis, Mamatha Bhat, Jan Clusmann, Joost Ph Drenth
JHEP Reports. 2025-02-01 - PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.Colleen M Hayes, Gina M Gallucci, James L Boyer, David N Assis, Nisanne S Ghonem
Hepatology Communications. 2025-01-01 - Pathophysiology of Cystic Fibrosis Liver Disease.Vania L Kasper, David N Assis
Pediatric Pulmonology. 2024-09-01
Press Mentions
- Prompt Diagnosis, Management of Primary Biliary Cholangitis Key to Quality of LifeDecember 23rd, 2024
- Expanded Treatment Options for Primary Biliary Cholangitis Leave Open QuestionsNovember 30th, 2024
- Managing Primary Biliary Cholangitis Progression and SymptomsNovember 15th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
